Published in Br J Pharmacol on July 01, 1996
Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol (1999) 0.94
Alpha1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries. Br J Pharmacol (2004) 0.86
A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonists. Br J Pharmacol (2001) 0.76
Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res (1977) 9.45
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev (1995) 2.53
Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol (1985) 2.37
Structure and function of small arteries. Physiol Rev (1990) 2.31
Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle. Br J Pharmacol (1990) 2.09
Novel dopamine receptors half a decade later. Trends Pharmacol Sci (1995) 1.86
Estimation of agonist affinity and efficacy by direct, operational model-fitting. J Pharmacol Methods (1990) 1.67
The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism. Eur J Pharmacol (1973) 1.65
Correlation of the directly observed responses of mesenteric vessles of the rat to nerve stimulation and noradrenaline with the distribution of adrenergic nerves. J Physiol (1974) 1.46
The Schild regression in the process of receptor classification. Can J Physiol Pharmacol (1982) 1.46
Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro. J Pharmacol Exp Ther (1984) 1.39
Alpha 1-adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol Sci (1994) 1.38
A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol (1977) 1.35
Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res (1993) 1.22
Effects of equilibration time on the attainment of equilibrium between antagonists and drug receptors. Eur J Pharmacol (1980) 1.20
Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists? Br J Pharmacol (1986) 1.19
Alpha-adrenoceptor subclassification by classical and response-related methods: same question, different answers. Trends Pharmacol Sci (1988) 1.18
What do antagonists tell us about alpha-adrenoceptors? Clin Sci (Lond) (1985) 1.16
Subtypes of alpha 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. Jpn J Pharmacol (1991) 1.14
Characterization of postsynaptic alpha-adrenoceptors in rat aortic strips and portal veins. Br J Pharmacol (1983) 1.13
The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype. Mol Pharmacol (1994) 1.05
Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex. Br J Pharmacol (1991) 1.04
Pharmacological characterization of the postsynaptic alpha adrenoceptors in vascular smooth muscle from canine and rat mesenteric vascular beds. J Pharmacol Exp Ther (1984) 1.04
Differential interactions of clonidine and methoxamine with the postsynaptic alpha-adrenoceptor of rabbit main pulmonary artery. J Cardiovasc Pharmacol (1983) 1.02
Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle. Mol Pharmacol (1994) 0.98
New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance. Am Heart J (1988) 0.98
Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat. J Pharmacol Exp Ther (1994) 0.98
Characterization of alpha 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat. Br J Pharmacol (1995) 0.96
On the postjunctional alpha-adrenoreceptors in rat cerebral and mesenteric arteries. J Auton Pharmacol (1984) 0.95
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br J Pharmacol (1995) 0.95
Competitive antagonism of alpha 1-adrenoceptor mediated pressor responses in the rat mesenteric artery. J Pharm Pharmacol (1984) 0.89
Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins. Evidence that D-1 dopamine receptors can couple to both Gs and G(o). J Biol Chem (1995) 0.87
The divergence in the excitation-contraction coupling of rat mesenteric resistance arteries lies distal to the receptor site. Eur J Pharmacol (1990) 0.86
Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries. Br J Pharmacol (1995) 0.84
Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices. J Neurochem (1994) 0.84
A novel role for dopamine: inhibition of muscarinic cholinergic-stimulated phosphoinositide hydrolysis in rat brain cortical membranes. Neurosci Lett (1990) 0.83
Difference in mode of action of alpha 1-adrenoceptor antagonists on some vascular smooth muscles and efficacy. Jpn J Pharmacol (1986) 0.81
Pharmacological characterization of the dopamine receptor coupled to cyclic AMP formation expressed by rat mesenteric artery vascular smooth muscle cells in culture. Br J Pharmacol (1993) 0.80
Definition and antagonism of histamine H 2 -receptors. Nature (1972) 18.58
Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci (1983) 6.89
Metiamide--an orally active histamine H2-receptor antagonist. Agents Actions (1973) 6.82
Comparison of some properties of pronethalol and propranolol. Br J Pharmacol Chemother (1965) 4.71
An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. Br J Pharmacol (1975) 2.91
International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev (1997) 2.71
An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol (1985) 2.68
Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol (1985) 2.37
The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis. Br J Pharmacol (1985) 2.25
Breast disease: dynamic spiral MR imaging. Radiology (1998) 1.89
Analysis of anomalous pKb values for metiamide and atropine in the isolated stomach of the mouse. Br J Pharmacol (1979) 1.78
Production of acid secretion in the mouse isolated stomach by electrical field stimulation [proceedings]. Br J Pharmacol (1978) 1.54
Effects in man of histamine H 2 -receptor blockade by burimamide. Lancet (1972) 1.51
The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Pharmacol (1975) 1.51
The pharmacological classification of practolol and chloropractolol. Mol Pharmacol (1978) 1.49
Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach. Br J Pharmacol (1985) 1.48
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev (1995) 1.45
Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay. Br J Pharmacol (1980) 1.45
Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach. Br J Pharmacol (1985) 1.42
Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach. Br J Pharmacol (1985) 1.23
Humoral immune response to the bovine immunodeficiency-like virus in experimentally and naturally infected cattle. J Virol (1990) 1.22
Pathogenic differences between various feline coronavirus isolates. Adv Exp Med Biol (1984) 1.21
Inotropic "A" ring substituted sulmazole and isomazole analogues. J Med Chem (1990) 1.21
The interaction of choline esters, vagal stimulation and H2-receptor blockade on acid secretion in vitro. Eur J Pharmacol (1982) 1.20
Correlation between log POCT/H2O and pKB estimates for a series of muscarinic and histamine H2-receptor antagonists. Br J Pharmacol (1988) 1.18
Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am J Vet Res (1983) 1.14
Comparative assay of histamine H2-receptor antagonists using the isolated mouse stomach [proceedings]. Br J Pharmacol (1978) 1.13
Idiopathic pulmonary haemosiderosis with myocarditis. Radio-isotope studies in a patient treated with prednisone. Thorax (1966) 1.11
Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant. Br J Pharmacol (1986) 1.09
Respiratory failure precipitated by high carbohydrate loads. Ann Intern Med (1981) 1.08
Cardiac-specific overexpression of human beta2 adrenoceptors in mice exposes coupling to both Gs and Gi proteins. Br J Pharmacol (2003) 1.06
Characterization of a new calicivirus isolated from feces of a dog. Arch Virol (1985) 1.04
Proceedings: Effects of dibutyryl cyclic AMP and phosphodiesterase inhibitors on acid secretion by mouse stomach in vitro. Br J Pharmacol (1976) 1.04
Antagonism of an indirectly acting agonist: block by propranolol and sotalol of the action of tyramine on rat heart. Eur J Pharmacol (1980) 1.04
Plaque assay, polypeptide composition and immunochemistry of feline infectious peritonitis virus and feline enteric coronavirus isolates. Adv Exp Med Biol (1984) 1.03
Are gastrin receptors located on parietal cells [proceedings]? Br J Pharmacol (1977) 1.02
Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action. Br J Pharmacol (1992) 1.01
Recovery and in vitro cultivation of a coronavirus from laboratory-induced cases of feline infectious peritonitis (FIP). Vet Med Small Anim Clin (1980) 0.99
Pharmacological analysis of beta-adrenoceptor-mediated agonism in the guinea-pig, isolated, right atrium. Br J Pharmacol (1985) 0.98
Pharmacological analysis of the inhibition by pirenzepine and atropine of vagal-stimulated acid secretion in the isolated stomach of the mouse. Br J Pharmacol (1986) 0.97
Parvoviral enteritis and panleukopenia in dogs. Vet Med Small Anim Clin (1979) 0.96
2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist. Br J Pharmacol (1993) 0.96
Analysis of the interaction between histamine H2-receptor antagonists and pentagastrin [proceedings]. Agents Actions (1978) 0.95
Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder. Br J Pharmacol (1992) 0.95
Sulphur-methylene isosterism in the development of metiamide, a new histamine H2-receptor antagonist. Nature (1974) 0.95
Breast lesion localization: a freehand, interactive MR imaging-guided technique. Radiology (1998) 0.93
An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle. Br J Pharmacol (2000) 0.92
TiPS on identity. Trends Pharmacol Sci (1996) 0.91
Pharmacological analysis of agonist-antagonist interactions at acetylcholine muscarinic receptors in a new urinary bladder assay. Br J Pharmacol (1991) 0.90
Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta. Br J Pharmacol (1996) 0.88
Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle. Br J Pharmacol (2002) 0.88
Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists. J Med Chem (2000) 0.88
The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development. Regul Pept (2010) 0.88
Histamine dependence of pentagastrin-stimulated gastric acid secretion in rats. Yale J Biol Med (1994) 0.87
Interpretation of agonist affinity estimations: the question of distributed receptor states. Proc R Soc Lond B Biol Sci (1990) 0.86
Pharmacological analysis of the interaction between purinoceptor agonists and antagonists in the guinea-pig taenia caecum. Br J Pharmacol (1995) 0.85
Activation and blockade of beta adrenoceptors in common cardiac disorders. Br Med Bull (1973) 0.85
Can chloropractolol alkylate beta adrenoceptors? Nature (1977) 0.85
Comparative analysis of the vagal stimulation of gastric acid secretion in rodent isolated stomach preparations. Br J Pharmacol (1994) 0.85
Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes. Br J Pharmacol (1999) 0.85
Pharmacological classification of adenosine receptors in the sinoatrial and atrioventricular nodes of the guinea-pig. Br J Pharmacol (1998) 0.84
Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex. Br J Pharmacol (1999) 0.84
Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries. Br J Pharmacol (1995) 0.84
Analysis of variation in L-365,260 competition curves in radioligand binding assays. Br J Pharmacol (1996) 0.83
Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays. Br J Pharmacol (1996) 0.83
Pharmacological characterization of cholecystokinin receptors mediating contraction of human gallbladder and ascending colon. Regul Pept (2002) 0.83
Resultant action of cimetidine in a cardiac adenylate cyclase assay: its elucidation by concentration-ratios analysis. J Pharmacol Exp Ther (1987) 0.82
Detection of a cell line contaminated with hog cholera virus. J Am Vet Med Assoc (1994) 0.82
Ahlquist and the development of beta-adrenoceptor antagonists. Postgrad Med J (1976) 0.82
Subsensitivity to epinephrine following the administration of epinephrine and ephedrine to normal individuals. J Allergy Clin Immunol (1975) 0.81
Comparative study of the control of basal acid output from rodent isolated stomachs. Br J Pharmacol (1993) 0.81
The magnitude of pitch inflection. Arch Psicol Neurol Psichiatr (1970) 0.81
Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists. J Med Chem (2000) 0.81
Can clinically relevant histamine release be accurately diagnosed in anaesthetised patients without plasma histamine measurements? Randomised study with nested sampling aimed to change paradigms. Inflamm Res (1998) 0.81
Clinical experience with metiamide. Fed Proc (1976) 0.80
Nonpeptide cholecystokinin-2 receptor agonists. J Med Chem (2001) 0.80